Latest data from net I was able to see is from June 2014, and was wondering, if any promising phase-3 clinical development has taken place in the last 9 months? Any of these potential block-busters heading to USFDA/EMEA for approval? 

More Kulvinder Singh Saini's questions See All
Similar questions and discussions